Skip to main content

Table 4 Characteristics of updated scoring guideline

From: An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort

Probe

Ratio cut-off

Borderline interval

Concordance

Mean number of scored nuclei

   

10 nuclei

20 nuclei

30 nuclei

10 nuclei

20 nuclei

30 nuclei

ERCC1- 19q13/CEN-2

1.5

none

0.71

0.87

0.89

10

20

30

  

1.35-1.65

0.86

0.93

0.99

15.3

26.4

36.5